By incorporating cells, biomaterials, and growth factors, 3D bioprinting can fabricate functional tissues that closely mimic natural structures. Recent advancements in 3D bioprinting have improved the quality of tissues by allowing the creation of complex skin substitutes and tissue constructs. The ability to precisely control the placement of cells and biomaterials enables the fabrication of tissues with improved structural integrity and biological functionality.

According to our latest market report, the global 3D bioprinting market size is projected to reach USD 23.1 billion by 2035 from USD 4.0 billion in 2024, growing at a CAGR of 17.2% in the forecast period 2024-2035.

Market Segments

Based on the type of component, the market is segmented into bioprinters, consumables and software.

The bioprinters segment is likely to capture the largest revenue share of more than 60% in the 3D bioprinting market, in 2024.

The bioprinters segment is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 18.5% during the forecast period.

Based on the type of consumable, the market is segmented into bioinks and other consumables.

The bioinks segment is likely to capture the largest revenue share of 75% in the 3D bioprinting market, in 2024.

The bioinks segment is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 17.8% during the forecast period.

Based on the type of technology, the market is segmented into extrusion-based, laser-based, stereolithography, inkjet-based and other technologies.

The extrusion-based segment is likely to capture the largest revenue share of more than 25% in the 3D bioprinting market, in 2024.

The stereolithography segment is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 20.0% during the forecast period.

Based on the type of material used, the market is segmented into living cells, hydrogels, and extracellular matrix.

The living cells segment is likely to capture the largest revenue share of 48% in the 3D bioprinting market, in 2024.

The living cells segment is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 18.2% during the forecast period.

Based on the application area, the market is segmented into regenerative medicine, tissue engineering, drug development, clinical testing and other application areas.

The regenerative medicine segment is likely to capture the largest revenue share of more than 30% in the 3D bioprinting market, in 2024.

The regenerative medicine segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 18.5% during the forecast period.

Based on the end user, the market is segmented into academic institutes, biopharmaceutical companies and clinical trials and research centers

The academic institutes segment is likely to capture the largest revenue share of close to 50% in the 3D bioprinting market, in 2024.

The biopharmaceutical companies segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 18.4% during the forecast period.

The key companies engaged in 3D bioprinting market (which have also been profiled in this market report; the complete list of companies is available in the full report) include (in alphabetic order) Advanced Solutions Life Sciences, Allevi, Aspect Biosystems, Cellink, CollPlant Biotechnologies, Cyfuse Biomedical K.K., Foldink, Formlabs, Inventia Life Science, it3d Group, Medprin Biotech, Organovo, Pandorum Technologies, Precise Bio, Regemat 3D, REGENHU, Rokit Healthcare, Stratasys and Vivax Bio.

Regional Outlook

Based on the geographical regions, the 3D bioprinting market can be segmented into five major regions, including North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa. North America is anticipated to capture the majority share of the 3D bioprinting market in 2024. Further, the 3D bioprinting industry in Latin America is accounted to be the fastest-growing segment of the market. This is primarily due to the rising adoption of 3D bioprinting solutions owing to the growing incidence of organ transplants. ?

Key Report Takeaways

Currently, more than 65 3D bioprinting solution providers are available across the world; majority of the solution providers are based in North America

Owing to the financial prosperity and the cultural norms present in the region, the US has emerged as a hub of the established players and the new entrants in this industry

Owing to technological advancements, the 3D bioprinting market is anticipated to witness an annualized growth of 17.2%, over the next decade

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Email: sales@rootsanalysis.com